The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of human cancers. [provided by RefSeq, Dec 2019]
- Enables transcription corepressor activity
- Enables protein kinase activity
- Enables protein binding
- Kinase activity
- Enables cyclin-dependent protein serine/threonine kinase regulator activity
- Part of cyclin-dependent protein kinase holoenzyme complex
- Located in nucleus
- Located in nucleoplasm
- Is active in cytoplasm
- Located in cytosol
- Involved in regulation of cyclin-dependent protein serine/threonine kinase activity
- Involved in G1/S transition of mitotic cell cycle
- Involved in negative regulation of transcription by RNA polymerase II
- Involved in re-entry into mitotic cell cycle
- Liver development
Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition (PubMed:1833066, PubMed:1827756, PubMed:8114739, PubMed:8302605, PubMed:19412162, PubMed:33854235). Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase (PubMed:1833066, PubMed:1827756, PubMed:8114739, PubMed:8302605, PubMed:19412162). Hypophosphorylates RB1 in early G(1) phase (PubMed:1833066, PubMed:1827756, PubMed:8114739, PubMed:8302605, PubMed:19412162). Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals (PubMed:1833066, PubMed:1827756, PubMed:8302605, PubMed:19412162). Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity (PubMed:15241418). Component of the ternary complex, cyclin D1/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex (PubMed:9106657). Exhibits transcriptional corepressor activity with INSM1 on the NEUROD1 and INS promoters in a cell cycle-independent manner (PubMed:16569215, PubMed:18417529). CCND1_HUMAN,P24385
- Von Hippel-Lindau Syndrom
- Myeloma, Multiple
- Mantle Cell Lymphoma
- Leukemia, Chronic Lymphocytic
- Colorectal Cancer
- Cervical Cancer
- Plasma Cell Leukemia
- Lymphoma
- Parathyroid Adenoma
- Bile Duct Cancer
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Adenoma
- Extramedullary Plasmacytoma
- Squamous Cell Carcinoma
- B-Cell Lymphoma
- Retinoblastoma
CCND1 (cyclin D1) – BioGPS
CCND1 Localizations – Subcellular Localization Database
The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of human cancers. [provided by RefSeq, Dec 2019]
- Enables transcription corepressor activity
- Enables protein kinase activity
- Enables protein binding
- Kinase activity
- Enables cyclin-dependent protein serine/threonine kinase regulator activity
- Part of cyclin-dependent protein kinase holoenzyme complex
- Located in nucleus
- Located in nucleoplasm
- Is active in cytoplasm
- Located in cytosol
- Involved in regulation of cyclin-dependent protein serine/threonine kinase activity
- Involved in G1/S transition of mitotic cell cycle
- Involved in negative regulation of transcription by RNA polymerase II
- Involved in re-entry into mitotic cell cycle
- Liver development
Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition (PubMed:1833066, PubMed:1827756, PubMed:8114739, PubMed:8302605, PubMed:19412162, PubMed:33854235). Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase (PubMed:1833066, PubMed:1827756, PubMed:8114739, PubMed:8302605, PubMed:19412162). Hypophosphorylates RB1 in early G(1) phase (PubMed:1833066, PubMed:1827756, PubMed:8114739, PubMed:8302605, PubMed:19412162). Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals (PubMed:1833066, PubMed:1827756, PubMed:8302605, PubMed:19412162). Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity (PubMed:15241418). Component of the ternary complex, cyclin D1/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex (PubMed:9106657). Exhibits transcriptional corepressor activity with INSM1 on the NEUROD1 and INS promoters in a cell cycle-independent manner (PubMed:16569215, PubMed:18417529). CCND1_HUMAN,P24385
- Von Hippel-Lindau Syndrom
- Myeloma, Multiple
- Mantle Cell Lymphoma
- Leukemia, Chronic Lymphocytic
- Colorectal Cancer
- Cervical Cancer
- Plasma Cell Leukemia
- Lymphoma
- Parathyroid Adenoma
- Bile Duct Cancer
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Adenoma
- Extramedullary Plasmacytoma
- Squamous Cell Carcinoma
- B-Cell Lymphoma
- Retinoblastoma
CCND1 (cyclin D1) – BioGPS
CCND1 Localizations – Subcellular Localization Database
Pleiotrope. Structure of protein CCND1.Based on PyMOL rendering of PDB 2W96.